🇺🇸 FDA
Patent

US 9702007

Genetic markers predictive of response to glatiramer acetate

granted A61KA61K38/02A61K38/16

Quick answer

US patent 9702007 (Genetic markers predictive of response to glatiramer acetate) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/02, A61K38/16, A61P, A61P25/00